{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:52:35Z","timestamp":1781823155656,"version":"3.54.5"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:00:00Z","timestamp":1767916800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biotechnol"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1007\/s12033-025-01546-x","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T08:25:15Z","timestamp":1767947115000},"page":"3124-3135","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Berberine Impedes Acute Pancreatitis Development by Suppressing VNN1 Expression and the NF-\u03baB Signaling Pathway"],"prefix":"10.1007","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0009-0009-1810-934X","authenticated-orcid":false,"given":"Jie","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjiang","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyu","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Qiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,9]]},"reference":[{"key":"1546_CR1","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1159\/000499138","volume":"35","author":"FU Weiss","year":"2019","unstructured":"Weiss, F. U., Laemmerhirt, F., & Lerch, M. M. (2019). Etiology and risk factors of acute and chronic pancreatitis. Visceral Medicine, 35, 73\u201381.","journal-title":"Visceral Medicine"},{"key":"1546_CR2","doi-asserted-by":"crossref","unstructured":"Chen, X., Zhong, R., & Hu, B. (2023). Mitochondrial dysfunction in the pathogenesis of acute pancreatitis. Hepatobiliary & Pancreatic Diseases International, 24(1), 76\u201383.","DOI":"10.1016\/j.hbpd.2023.12.008"},{"key":"1546_CR3","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/S0140-6736(20)31318-0","volume":"396","author":"G Beyer","year":"2020","unstructured":"Beyer, G., Habtezion, A., Werner, J., Lerch, M. M., & Mayerle, J. (2020). Chronic pancreatitis. Lancet, 396, 499\u2013512.","journal-title":"Lancet"},{"key":"1546_CR4","doi-asserted-by":"publisher","first-page":"1202","DOI":"10.1097\/MPA.0000000000001657","volume":"49","author":"O Osagiede","year":"2020","unstructured":"Osagiede, O., Lukens, F. J., Wijarnpreecha, K., et al. (2020). Acute pancreatitis in celiac disease: Has the inpatient prevalence changed and is it associated with worse outcomes? Pancreas, 49, 1202\u20131206.","journal-title":"Pancreas"},{"key":"1546_CR5","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1053\/j.gastro.2021.09.043","volume":"162","author":"JP Iannuzzi","year":"2022","unstructured":"Iannuzzi, J. P., King, J. A., Leong, J. H., et al. (2022). Global incidence of acute pancreatitis is increasing over time: A systematic review and meta-analysis. Gastroenterology, 162, 122\u2013134.","journal-title":"Gastroenterology"},{"key":"1546_CR6","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/s12876-021-01799-1","volume":"21","author":"C Sun","year":"2021","unstructured":"Sun, C., Li, Z., Shi, Z., & Li, G. (2021). Current diagnosis and treatment of acute pancreatitis in China: A real-world, multicenter study. BMC Gastroenterology, 21, 210.","journal-title":"BMC Gastroenterology"},{"key":"1546_CR7","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s11684-019-0724-6","volume":"14","author":"D Song","year":"2020","unstructured":"Song, D., Hao, J., & Fan, D. (2020). Biological properties and clinical applications of berberine. Frontiers in Medicine, 14, 564\u2013582.","journal-title":"Frontiers in Medicine"},{"key":"1546_CR8","doi-asserted-by":"publisher","first-page":"3872","DOI":"10.2174\/0115701808291656240722095841","volume":"21","author":"M Jin-Rong","year":"2024","unstructured":"Jin-Rong, M., Qiu-Rong, H., Ruo-Jun, M., Linguo, Z., & Dong-Dong, L. (2024). Dynamic comparison of binding pocket of berberine protein crystals. Letters in Drug Design & Discovery, 21, 3872\u20133885.","journal-title":"Letters in Drug Design & Discovery"},{"key":"1546_CR9","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104722","volume":"155","author":"S Habtemariam","year":"2020","unstructured":"Habtemariam, S. (2020). Berberine pharmacology and the gut microbiota: A hidden therapeutic link. Pharmacological Research, 155, Article 104722.","journal-title":"Pharmacological Research"},{"key":"1546_CR10","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/978-3-319-41334-1_2","volume":"928","author":"AF Cicero","year":"2016","unstructured":"Cicero, A. F., & Baggioni, A. (2016). Berberine and Its Role in Chronic Disease. Advances in Experimental Medicine and Biology, 928, 27\u201345.","journal-title":"Advances in Experimental Medicine and Biology"},{"key":"1546_CR11","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1080\/03602532.2017.1306544","volume":"49","author":"K Wang","year":"2017","unstructured":"Wang, K., Feng, X., Chai, L., Cao, S., & Qiu, F. (2017). The metabolism of berberine and its contribution to the pharmacological effects. Drug Metabolism Reviews, 49, 139\u2013157.","journal-title":"Drug Metabolism Reviews"},{"key":"1546_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110984","volume":"133","author":"X Xu","year":"2021","unstructured":"Xu, X., Yi, H., Wu, J., et al. (2021). Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomedicine & Pharmacotherapy, 133, Article 110984.","journal-title":"Biomedicine & Pharmacotherapy"},{"key":"1546_CR13","doi-asserted-by":"publisher","DOI":"10.3390\/molecules26237368","author":"A Rauf","year":"2021","unstructured":"Rauf, A., Abu-Izneid, T., & Khalil, A. A. (2021). Berberine as a potential anticancer agent: A comprehensive review. Molecules, 26(23), Article 7368.","journal-title":"Molecules"},{"key":"1546_CR14","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.588517","volume":"10","author":"L Zhang","year":"2020","unstructured":"Zhang, L., Wu, X., Yang, R., et al. (2020). Effects of Berberine on the Gastrointestinal Microbiota. Frontiers in Cellular and Infection Microbiology, 10, Article 588517.","journal-title":"Frontiers in Cellular and Infection Microbiology"},{"key":"1546_CR15","doi-asserted-by":"publisher","first-page":"1923","DOI":"10.7150\/thno.30787","volume":"9","author":"X Feng","year":"2019","unstructured":"Feng, X., Sureda, A., Jafari, S., et al. (2019). Berberine in cardiovascular and metabolic diseases: From mechanisms to therapeutics. Theranostics, 9, 1923\u20131951.","journal-title":"Theranostics"},{"key":"1546_CR16","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.845591","volume":"13","author":"Z Cheng","year":"2022","unstructured":"Cheng, Z., Kang, C., Che, S., et al. (2022). Berberine: A Promising Treatment for Neurodegenerative Diseases. Frontiers in Pharmacology, 13, Article 845591.","journal-title":"Frontiers in Pharmacology"},{"key":"1546_CR17","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27144523","author":"RG Xiong","year":"2022","unstructured":"Xiong, R. G., Huang, S. Y., Wu, S. X., et al. (2022). Anticancer effects and mechanisms of berberine from medicinal herbs: An update review. Molecules,\u00a027(14), Article 4523.\u00a0","journal-title":"Molecules"},{"key":"1546_CR18","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.jpha.2021.10.003","volume":"12","author":"H Cheng","year":"2022","unstructured":"Cheng, H., Liu, J., Tan, Y., Feng, W., & Peng, C. (2022). Interactions between gut microbiota and berberine, a necessary procedure to understand the mechanisms of berberine. Journal of Pharmaceutical Analysis, 12, 541\u2013555.","journal-title":"Journal of Pharmaceutical Analysis"},{"key":"1546_CR19","doi-asserted-by":"publisher","first-page":"1187718","DOI":"10.3389\/fnut.2023.1187718","volume":"10","author":"F Yang","year":"2023","unstructured":"Yang, F., Gao, R., Luo, X., Liu, R., & Xiong, D. (2023). Berberine influences multiple diseases by modifying gut microbiota. Frontiers in Nutrition, 10, 1187718.","journal-title":"Frontiers in Nutrition"},{"key":"1546_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2022.913378","volume":"13","author":"S Yang","year":"2022","unstructured":"Yang, S., Cao, S., Li, C., et al. (2022). Berberrubine, a main metabolite of berberine, alleviates non-alcoholic fatty liver disease via modulating glucose and lipid metabolism and restoring gut microbiota. Frontiers in Pharmacology, 13, Article 913378.","journal-title":"Frontiers in Pharmacology"},{"key":"1546_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.apsb.2012.06.003","volume":"2","author":"J Yin","year":"2012","unstructured":"Yin, J., Ye, J., & Jia, W. (2012). Effects and mechanisms of berberine in diabetes treatment. Acta Pharmaceutica Sinica B, 2, 327\u2013334.","journal-title":"Acta Pharmaceutica Sinica B"},{"key":"1546_CR22","first-page":"3009","volume":"17","author":"C Cao","year":"2019","unstructured":"Cao, C., & Su, M. (2019). Effects of berberine on glucose-lipid metabolism, inflammatory factors and insulin resistance in patients with metabolic syndrome. Experimental and Therapeutic Medicine, 17, 3009\u20133014.","journal-title":"Experimental and Therapeutic Medicine"},{"key":"1546_CR23","doi-asserted-by":"publisher","first-page":"1501","DOI":"10.1002\/ptr.6107","volume":"32","author":"X Lin","year":"2018","unstructured":"Lin, X., & Zhang, N. (2018). Berberine: Pathways to protect neurons. Phytotherapy Research, 32, 1501\u20131510.","journal-title":"Phytotherapy Research"},{"key":"1546_CR24","doi-asserted-by":"publisher","first-page":"4208","DOI":"10.1080\/07391102.2020.1854857","volume":"40","author":"AB Gurung","year":"2022","unstructured":"Gurung, A. B., Bhutia, J. T., & Bhattacharjee, A. (2022). High-throughput virtual screening of novel potent inhibitor(s) for Human Vanin-1 enzyme. Journal of Biomolecular Structure & Dynamics, 40, 4208\u20134223.","journal-title":"Journal of Biomolecular Structure & Dynamics"},{"key":"1546_CR25","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.hrtlng.2022.06.022","volume":"56","author":"X Zhang","year":"2022","unstructured":"Zhang, X., Cong, W., & Lu, A. (2022). Vanin-1 as a novel biomarker for chronic obstructive pulmonary disease. Heart & Lung, 56, 91\u201395.","journal-title":"Heart & Lung"},{"key":"1546_CR26","doi-asserted-by":"publisher","DOI":"10.1128\/ecosalplus.3.6.3.4","author":"R Leonardi","year":"2007","unstructured":"Leonardi, R., & Jackowski, S. (2007). Biosynthesis of pantothenic acid and coenzyme A. EcoSal Plus,\u00a02(2), Article 10.\u00a0","journal-title":"EcoSal Plus"},{"key":"1546_CR27","doi-asserted-by":"publisher","DOI":"10.1128\/IAI.00947-17","author":"DJ Fraser-Pitt","year":"2018","unstructured":"Fraser-Pitt, D. J., & Mercer, D. K. (2018). Cysteamine, an endogenous aminothiol, and cystamine, the disulfide product of oxidation, increase Pseudomonas aeruginosa sensitivity to reactive oxygen and nitrogen species and potentiate therapeutic antibiotics against bacterial infection. Infection and Immunity, 86(6), 947\u2013917.\u00a0","journal-title":"Infection and Immunity"},{"key":"1546_CR28","doi-asserted-by":"publisher","first-page":"e22472","DOI":"10.1096\/fj.202200496RR","volume":"36","author":"J Chen","year":"2022","unstructured":"Chen, J., Lu, H., Wang, X., et al. (2022). VNN1 contributes to the acute kidney injury-chronic kidney disease transition by promoting cellular senescence via affecting RB1 expression. FASEB Journal, 36, e22472.","journal-title":"FASEB Journal"},{"key":"1546_CR29","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20163891","author":"R Bartucci","year":"2019","unstructured":"Bartucci, R., & Salvati, A. (2019). Vanin 1: Its physiological function and role in diseases. International Journal of Molecular Sciences,\u00a020(16), Article 3891.\u00a0","journal-title":"International Journal of Molecular Sciences"},{"key":"1546_CR30","doi-asserted-by":"publisher","first-page":"1236484","DOI":"10.3389\/fmed.2023.1236484","volume":"10","author":"W Guan","year":"2023","unstructured":"Guan, W., Xu, J., Shi, Y., et al. (2023). VNN1 as a potential biomarker for sepsis diagnosis and its implications in immune infiltration and tumor prognosis. Frontiers in Medicine, 10, 1236484.","journal-title":"Frontiers in Medicine"},{"key":"1546_CR31","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2023.176220","volume":"962","author":"H Yu","year":"2024","unstructured":"Yu, H., Cui, Y., Guo, F., et al. (2024). Vanin1 (VNN1) in chronic diseases: Future directions for targeted therapy. European Journal of Pharmacology, 962, Article 176220.","journal-title":"European Journal of Pharmacology"},{"key":"1546_CR32","doi-asserted-by":"publisher","DOI":"10.3390\/cells12010065","author":"TJ Song","year":"2022","unstructured":"Song, T. J., Ke, J., Chen, F., et al. (2022). Effect of SNHG11\/miR-7-5p\/PLCB1 axis on acute pancreatitis through inhibiting p38MAPK pathway. Cells,\u00a012(1), Article 65.","journal-title":"Cells"},{"key":"1546_CR33","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.tibs.2022.10.002","volume":"48","author":"J Xu","year":"2023","unstructured":"Xu, J., & N\u00fa\u00f1ez, G. (2023). The NLRP3 inflammasome: Activation and regulation. Trends in Biochemical Sciences, 48, 331\u2013344.","journal-title":"Trends in Biochemical Sciences"},{"key":"1546_CR34","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1038\/s41590-023-01526-w","volume":"24","author":"P Devant","year":"2023","unstructured":"Devant, P., & Kagan, J. C. (2023). Molecular mechanisms of gasdermin D pore-forming activity. Nature Immunology, 24, 1064\u20131075.","journal-title":"Nature Immunology"},{"key":"1546_CR35","doi-asserted-by":"publisher","first-page":"117793222110303","DOI":"10.1177\/11779322211030364","volume":"15","author":"A Ahmed","year":"2021","unstructured":"Ahmed, A., & Mam, B. (2021). DEELIG: A deep learning approach to predict protein-ligand binding affinity. Bioinformatics and Biology Insights, 15, 11779322211030364.","journal-title":"Bioinformatics and Biology Insights"},{"key":"1546_CR36","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1007\/s11739-024-03666-9","volume":"19","author":"D Padula","year":"2024","unstructured":"Padula, D., & Mauro, A. (2024). Practical approach to acute pancreatitis: From diagnosis to the management of complications. Internal and Emergency Medicine, 19, 2091\u20132104.","journal-title":"Internal and Emergency Medicine"},{"key":"1546_CR37","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1186\/s40164-023-00444-9","volume":"12","author":"GL Varaprasad","year":"2023","unstructured":"Varaprasad, G. L., Gupta, V. K., Prasad, K., et al. (2023). Recent advances and future perspectives in the therapeutics of prostate cancer. Experimental Hematology & Oncology, 12, 80.","journal-title":"Experimental Hematology & Oncology"},{"key":"1546_CR38","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/S0140-6736(20)31310-6","volume":"396","author":"L Boxhoorn","year":"2020","unstructured":"Boxhoorn, L., Voermans, R. P., Bouwense, S. A., et al. (2020). Acute pancreatitis. Lancet, 396, 726\u2013734.","journal-title":"Lancet"},{"key":"1546_CR39","doi-asserted-by":"publisher","first-page":"2287","DOI":"10.2147\/JIR.S485804","volume":"18","author":"M Luo","year":"2025","unstructured":"Luo, M., Ting, J., Yi, F., et al. (2025). Signaling Pathways Involved in Acute Pancreatitis. Journal of Inflammation Research., 18, 2287\u20132303.","journal-title":"Journal of Inflammation Research."},{"key":"1546_CR40","doi-asserted-by":"publisher","first-page":"1287750","DOI":"10.3389\/fphar.2023.1287750","volume":"14","author":"L Dan","year":"2023","unstructured":"Dan, L., Hao, Y., Li, J., et al. (2023). Neuroprotective effects and possible mechanisms of berberine in animal models of Alzheimer\u2019s disease: A systematic review and meta-analysis. Frontiers in Pharmacology, 14, 1287750.","journal-title":"Frontiers in Pharmacology"},{"key":"1546_CR41","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1186\/s12967-024-05011-2","volume":"22","author":"Q Nie","year":"2024","unstructured":"Nie, Q., Li, M., Huang, C., et al. (2024). The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: A meta-analysis and systematic review. Journal of Translational Medicine, 22, 225.","journal-title":"Journal of Translational Medicine"},{"key":"1546_CR42","doi-asserted-by":"publisher","first-page":"951","DOI":"10.1189\/jlb.0512265","volume":"92","author":"A Rubartelli","year":"2012","unstructured":"Rubartelli, A. (2012). Redox control of NLRP3 inflammasome activation in health and disease. Journal of Leukocyte Biology, 92, 951\u2013958.","journal-title":"Journal of Leukocyte Biology"},{"key":"1546_CR43","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201747404","author":"R Heilig","year":"2018","unstructured":"Heilig, R., Dick, M. S., Sborgi, L., et al. (2018). The gasdermin\u2010D pore acts as a conduit for IL\u20101\u03b2 secretion in mice. European Journal of Immunology,\u00a048(4), 584\u2013592.\u00a0","journal-title":"European Journal of Immunology"},{"key":"1546_CR44","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1016\/j.canlet.2015.12.031","volume":"373","author":"M Kang","year":"2016","unstructured":"Kang, M., Qin, W., Buya, M., et al. (2016). VNN1, a potential biomarker for pancreatic cancer-associated new-onset diabetes, aggravates paraneoplastic islet dysfunction by increasing oxidative stress. Cancer Letters, 373, 241\u2013250.","journal-title":"Cancer Letters"},{"key":"1546_CR45","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1042\/BST20140092","volume":"42","author":"P Naquet","year":"2014","unstructured":"Naquet, P., Pitari, G., Dupr\u00e8, S., & Galland, F. (2014). Role of the Vnn1 pantetheinase in tissue tolerance to stress. Biochemical Society Transactions, 42, 1094\u20131100.","journal-title":"Biochemical Society Transactions"},{"key":"1546_CR46","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.7150\/thno.54245","volume":"11","author":"H Xiang","year":"2021","unstructured":"Xiang, H., Guo, F., Tao, X., et al. (2021). Pancreatic ductal deletion of S100A9 alleviates acute pancreatitis by targeting VNN1-mediated ROS release to inhibit NLRP3 activation. Theranostics, 11, 4467\u20134482.","journal-title":"Theranostics"},{"key":"1546_CR47","doi-asserted-by":"crossref","unstructured":"Xing, Y., Wei, H., Xiao, X., et al. (2020). Methylated Vnn1 at promoter regions induces asthma occurrence via the PI3K\/Akt\/NF\u03baB-mediated inflammation in IUGR mice. Biology Open, 9(4), 49106.","DOI":"10.1242\/bio.049106"}],"container-title":["Molecular Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-025-01546-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12033-025-01546-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12033-025-01546-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T22:02:33Z","timestamp":1781820153000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12033-025-01546-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,9]]},"references-count":47,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["1546"],"URL":"https:\/\/doi.org\/10.1007\/s12033-025-01546-x","relation":{},"ISSN":["1073-6085","1559-0305"],"issn-type":[{"value":"1073-6085","type":"print"},{"value":"1559-0305","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,9]]},"assertion":[{"value":"12 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}},{"value":"The present study was approved by the ethical review committee of Shengzhou People\u2019s Hospital. Written informed consent was obtained from all enrolled patients.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"Patients agree to participate in this work","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}}]}}